Myomectomy Market - Global Outlook and Forecast 2021-2027

April 2021 | 91 pages | ID: MA53C8F550D6EN
Market Monitor Global

Abstracts

This report contains market size and forecasts of Myomectomy in Global, including the following market information:

Global Myomectomy Market Revenue, 2016-2021, 2022-2027, ($ millions)

Global top five companies in 2020 (%)

The global Myomectomy market was valued at XX million in 2020 and is projected to reach US$ XX million by 2027, at a CAGR of XX% during the forecast period.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Myomectomy companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Myomectomy Market, By Type, 2016-2021, 2022-2027 ($ millions)

Global Myomectomy Market Segment Percentages, By Type, 2020 (%)

• Abdominal Myomectomy
• Hysteroscopic Myomectomy
• Laparoscopic Myomectomy

China Myomectomy Market, By Application, 2016-2021, 2022-2027 ($ millions)

China Myomectomy Market Segment Percentages, By Application, 2020 (%)

• Hospital
• Clinic
• Others

Global Myomectomy Market, By Region and Country, 2016-2021, 2022-2027 ($ Millions)

Global Myomectomy Market Segment Percentages, By Region and Country, 2020 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Total Myomectomy Market Competitors Revenues in Global, by Players 2016-2021 (Estimated), ($ millions)

Total Myomectomy Market Competitors Revenues Share in Global, by Players 2020 (%)

Further, the report presents profiles of competitors in the market, including the following:

• Medtronic
• Stryker Corporation
• CONMED Corporation
• INSIGHTEC
• CooperSurgical Inc.
• Hologic, Inc.
• Intuitive Surgical
• Karl Storz
• B. Braun Melsungen AG

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Neuromyelitis Optica Spectrum Disorder (NMOSD) Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Neuromyelitis Optica Spectrum Disorder (NMOSD) Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL NEUROMYELITIS OPTICA SPECTRUM DISORDER (NMOSD) OVERALL MARKET SIZE

2.1 Global Neuromyelitis Optica Spectrum Disorder (NMOSD) Market Size: 2021 VS 2027
2.2 Global Neuromyelitis Optica Spectrum Disorder (NMOSD) Market Size, Prospects & Forecasts: 2016-2027
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Neuromyelitis Optica Spectrum Disorder (NMOSD) Players in Global Market
3.2 Top Global Neuromyelitis Optica Spectrum Disorder (NMOSD) Companies Ranked by Revenue
3.3 Global Neuromyelitis Optica Spectrum Disorder (NMOSD) Revenue by Companies
3.4 Top 3 and Top 5 Neuromyelitis Optica Spectrum Disorder (NMOSD) Companies in Global Market, by Revenue in 2020
3.5 Global Companies Neuromyelitis Optica Spectrum Disorder (NMOSD) Product Type
3.6 Tier 1, Tier 2 and Tier 3 Neuromyelitis Optica Spectrum Disorder (NMOSD) Players in Global Market
  3.6.1 List of Global Tier 1 Neuromyelitis Optica Spectrum Disorder (NMOSD) Companies
  3.6.2 List of Global Tier 2 and Tier 3 Neuromyelitis Optica Spectrum Disorder (NMOSD) Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 By Type - Global Neuromyelitis Optica Spectrum Disorder (NMOSD) Market Size Markets, 2021 & 2027
  4.1.2 Intravenous
  4.1.3 Oral
  4.1.4 Subcutaneous
  4.1.5 Others
4.2 By Type - Global Neuromyelitis Optica Spectrum Disorder (NMOSD) Revenue & Forecasts
  4.2.1 By Type - Global Neuromyelitis Optica Spectrum Disorder (NMOSD) Revenue, 2016-2021
  4.2.2 By Type - Global Neuromyelitis Optica Spectrum Disorder (NMOSD) Revenue, 2022-2027
  4.2.3 By Type - Global Neuromyelitis Optica Spectrum Disorder (NMOSD) Revenue Market Share, 2016-2027

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Neuromyelitis Optica Spectrum Disorder (NMOSD) Market Size, 2021 & 2027
  5.1.2 Hospital
  5.1.3 Clinic
  5.1.4 Others
5.2 By Application - Global Neuromyelitis Optica Spectrum Disorder (NMOSD) Revenue & Forecasts
  5.2.1 By Application - Global Neuromyelitis Optica Spectrum Disorder (NMOSD) Revenue, 2016-2021
  5.2.2 By Application - Global Neuromyelitis Optica Spectrum Disorder (NMOSD) Revenue, 2022-2027
  5.2.3 By Application - Global Neuromyelitis Optica Spectrum Disorder (NMOSD) Revenue Market Share, 2016-2027

6 SIGHTS BY REGION

6.1 By Region - Global Neuromyelitis Optica Spectrum Disorder (NMOSD) Market Size, 2021 & 2027
6.2 By Region - Global Neuromyelitis Optica Spectrum Disorder (NMOSD) Revenue & Forecasts
  6.2.1 By Region - Global Neuromyelitis Optica Spectrum Disorder (NMOSD) Revenue, 2016-2021
  6.2.2 By Region - Global Neuromyelitis Optica Spectrum Disorder (NMOSD) Revenue, 2022-2027
  6.2.3 By Region - Global Neuromyelitis Optica Spectrum Disorder (NMOSD) Revenue Market Share, 2016-2027
6.3 North America
  6.3.1 By Country - North America Neuromyelitis Optica Spectrum Disorder (NMOSD) Revenue, 2016-2027
  6.3.2 US Neuromyelitis Optica Spectrum Disorder (NMOSD) Market Size, 2016-2027
  6.3.3 Canada Neuromyelitis Optica Spectrum Disorder (NMOSD) Market Size, 2016-2027
  6.3.4 Mexico Neuromyelitis Optica Spectrum Disorder (NMOSD) Market Size, 2016-2027
6.4 Europe
  6.4.1 By Country - Europe Neuromyelitis Optica Spectrum Disorder (NMOSD) Revenue, 2016-2027
  6.4.2 Germany Neuromyelitis Optica Spectrum Disorder (NMOSD) Market Size, 2016-2027
  6.4.3 France Neuromyelitis Optica Spectrum Disorder (NMOSD) Market Size, 2016-2027
  6.4.4 U.K. Neuromyelitis Optica Spectrum Disorder (NMOSD) Market Size, 2016-2027
  6.4.5 Italy Neuromyelitis Optica Spectrum Disorder (NMOSD) Market Size, 2016-2027
  6.4.6 Russia Neuromyelitis Optica Spectrum Disorder (NMOSD) Market Size, 2016-2027
  6.4.7 Nordic Countries Neuromyelitis Optica Spectrum Disorder (NMOSD) Market Size, 2016-2027
  6.4.8 Benelux Neuromyelitis Optica Spectrum Disorder (NMOSD) Market Size, 2016-2027
6.5 Asia
  6.5.1 By Region - Asia Neuromyelitis Optica Spectrum Disorder (NMOSD) Revenue, 2016-2027
  6.5.2 China Neuromyelitis Optica Spectrum Disorder (NMOSD) Market Size, 2016-2027
  6.5.3 Japan Neuromyelitis Optica Spectrum Disorder (NMOSD) Market Size, 2016-2027
  6.5.4 South Korea Neuromyelitis Optica Spectrum Disorder (NMOSD) Market Size, 2016-2027
  6.5.5 Southeast Asia Neuromyelitis Optica Spectrum Disorder (NMOSD) Market Size, 2016-2027
  6.5.6 India Neuromyelitis Optica Spectrum Disorder (NMOSD) Market Size, 2016-2027
6.6 South America
  6.6.1 By Country - South America Neuromyelitis Optica Spectrum Disorder (NMOSD) Revenue, 2016-2027
  6.6.2 Brazil Neuromyelitis Optica Spectrum Disorder (NMOSD) Market Size, 2016-2027
  6.6.3 Argentina Neuromyelitis Optica Spectrum Disorder (NMOSD) Market Size, 2016-2027
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Neuromyelitis Optica Spectrum Disorder (NMOSD) Revenue, 2016-2027
  6.7.2 Turkey Neuromyelitis Optica Spectrum Disorder (NMOSD) Market Size, 2016-2027
  6.7.3 Israel Neuromyelitis Optica Spectrum Disorder (NMOSD) Market Size, 2016-2027
  6.7.4 Saudi Arabia Neuromyelitis Optica Spectrum Disorder (NMOSD) Market Size, 2016-2027
  6.7.5 UAE Neuromyelitis Optica Spectrum Disorder (NMOSD) Market Size, 2016-2027

7 PLAYERS PROFILES

7.1 F. Hoffmann-La Roche Ltd
  7.1.1 F. Hoffmann-La Roche Ltd Corporate Summary
  7.1.2 F. Hoffmann-La Roche Ltd Business Overview
  7.1.3 F. Hoffmann-La Roche Ltd Neuromyelitis Optica Spectrum Disorder (NMOSD) Major Product Offerings
  7.1.4 F. Hoffmann-La Roche Ltd Neuromyelitis Optica Spectrum Disorder (NMOSD) Revenue in Global (2016-2021)
  7.1.5 F. Hoffmann-La Roche Ltd Key News
7.2 Alexion Pharmaceuticals
  7.2.1 Alexion Pharmaceuticals Corporate Summary
  7.2.2 Alexion Pharmaceuticals Business Overview
  7.2.3 Alexion Pharmaceuticals Neuromyelitis Optica Spectrum Disorder (NMOSD) Major Product Offerings
  7.2.4 Alexion Pharmaceuticals Neuromyelitis Optica Spectrum Disorder (NMOSD) Revenue in Global (2016-2021)
  7.2.5 Alexion Pharmaceuticals Key News
7.3 RemeGen
  7.3.1 RemeGen Corporate Summary
  7.3.2 RemeGen Business Overview
  7.3.3 RemeGen Neuromyelitis Optica Spectrum Disorder (NMOSD) Major Product Offerings
  7.3.4 RemeGen Neuromyelitis Optica Spectrum Disorder (NMOSD) Revenue in Global (2016-2021)
  7.3.5 RemeGen Key News
7.4 Nihon Pharmaceutical
  7.4.1 Nihon Pharmaceutical Corporate Summary
  7.4.2 Nihon Pharmaceutical Business Overview
  7.4.3 Nihon Pharmaceutical Neuromyelitis Optica Spectrum Disorder (NMOSD) Major Product Offerings
  7.4.4 Nihon Pharmaceutical Neuromyelitis Optica Spectrum Disorder (NMOSD) Revenue in Global (2016-2021)
  7.4.5 Nihon Pharmaceutical Key News
7.5 Harbour BioMed
  7.5.1 Harbour BioMed Corporate Summary
  7.5.2 Harbour BioMed Business Overview
  7.5.3 Harbour BioMed Neuromyelitis Optica Spectrum Disorder (NMOSD) Major Product Offerings
  7.5.4 Harbour BioMed Neuromyelitis Optica Spectrum Disorder (NMOSD) Revenue in Global (2016-2021)
  7.5.5 Harbour BioMed Key News
7.6 Lundbeck
  7.6.1 Lundbeck Corporate Summary
  7.6.2 Lundbeck Business Overview
  7.6.3 Lundbeck Neuromyelitis Optica Spectrum Disorder (NMOSD) Major Product Offerings
  7.6.4 Lundbeck Neuromyelitis Optica Spectrum Disorder (NMOSD) Revenue in Global (2016-2021)
  7.6.5 Lundbeck Key News
7.7 Bionure
  7.7.1 Bionure Corporate Summary
  7.7.2 Bionure Business Overview
  7.7.3 Bionure Neuromyelitis Optica Spectrum Disorder (NMOSD) Major Product Offerings
  7.4.4 Bionure Neuromyelitis Optica Spectrum Disorder (NMOSD) Revenue in Global (2016-2021)
  7.7.5 Bionure Key News
7.8 Opexa Therapeutics
  7.8.1 Opexa Therapeutics Corporate Summary
  7.8.2 Opexa Therapeutics Business Overview
  7.8.3 Opexa Therapeutics Neuromyelitis Optica Spectrum Disorder (NMOSD) Major Product Offerings
  7.8.4 Opexa Therapeutics Neuromyelitis Optica Spectrum Disorder (NMOSD) Revenue in Global (2016-2021)
  7.8.5 Opexa Therapeutics Key News
7.9 TG Therapeutics
  7.9.1 TG Therapeutics Corporate Summary
  7.9.2 TG Therapeutics Business Overview
  7.9.3 TG Therapeutics Neuromyelitis Optica Spectrum Disorder (NMOSD) Major Product Offerings
  7.9.4 TG Therapeutics Neuromyelitis Optica Spectrum Disorder (NMOSD) Revenue in Global (2016-2021)
  7.9.5 TG Therapeutics Key News
7.10 Bio-Thera Solutions
  7.10.1 Bio-Thera Solutions Corporate Summary
  7.10.2 Bio-Thera Solutions Business Overview
  7.10.3 Bio-Thera Solutions Neuromyelitis Optica Spectrum Disorder (NMOSD) Major Product Offerings
  7.10.4 Bio-Thera Solutions Neuromyelitis Optica Spectrum Disorder (NMOSD) Revenue in Global (2016-2021)
  7.10.5 Bio-Thera Solutions Key News
7.11 Boston Pharmaceuticals
  7.11.1 Boston Pharmaceuticals Corporate Summary
  7.11.2 Boston Pharmaceuticals Business Overview
  7.11.3 Boston Pharmaceuticals Neuromyelitis Optica Spectrum Disorder (NMOSD) Major Product Offerings
  7.11.4 Boston Pharmaceuticals Neuromyelitis Optica Spectrum Disorder (NMOSD) Revenue in Global (2016-2021)
  7.11.5 Boston Pharmaceuticals Key News
7.12 Cour Pharmaceutical
  7.12.1 Cour Pharmaceutical Corporate Summary
  7.12.2 Cour Pharmaceutical Business Overview
  7.12.3 Cour Pharmaceutical Neuromyelitis Optica Spectrum Disorder (NMOSD) Major Product Offerings
  7.12.4 Cour Pharmaceutical Neuromyelitis Optica Spectrum Disorder (NMOSD) Revenue in Global (2016-2021)
  7.12.5 Cour Pharmaceutical Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Myomectomy Market Opportunities & Trends in Global Market
Table 2. Myomectomy Market Drivers in Global Market
Table 3. Myomectomy Market Restraints in Global Market
Table 4. Key Players of Myomectomy in Global Market
Table 5. Top Myomectomy Players in Global Market, Ranking by Revenue (2019)
Table 6. Global Myomectomy Revenue by Companies, (US$, Mn), 2016-2021
Table 7. Global Myomectomy Revenue Share by Companies, 2016-2021
Table 8. Global Companies Myomectomy Product Type
Table 9. List of Global Tier 1 Myomectomy Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Myomectomy Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type – Global Myomectomy Revenue, (US$, Mn), 2021 VS 2027
Table 12. By Type - Myomectomy Revenue in Global (US$, Mn), 2016-2021
Table 13. By Type - Myomectomy Revenue in Global (US$, Mn), 2022-2027
Table 14. By Application – Global Myomectomy Revenue, (US$, Mn), 2021 VS 2027
Table 15. By Application - Myomectomy Revenue in Global (US$, Mn), 2016-2021
Table 16. By Application - Myomectomy Revenue in Global (US$, Mn), 2022-2027
Table 17. By Region – Global Myomectomy Revenue, (US$, Mn), 2021 VS 2027
Table 18. By Region - Global Myomectomy Revenue (US$, Mn), 2016-2021
Table 19. By Region - Global Myomectomy Revenue (US$, Mn), 2022-2027
Table 20. By Country - North America Myomectomy Revenue, (US$, Mn), 2016-2021
Table 21. By Country - North America Myomectomy Revenue, (US$, Mn), 2022-2027
Table 22. By Country - Europe Myomectomy Revenue, (US$, Mn), 2016-2021
Table 23. By Country - Europe Myomectomy Revenue, (US$, Mn), 2022-2027
Table 24. By Region - Asia Myomectomy Revenue, (US$, Mn), 2016-2021
Table 25. By Region - Asia Myomectomy Revenue, (US$, Mn), 2022-2027
Table 26. By Country - South America Myomectomy Revenue, (US$, Mn), 2016-2021
Table 27. By Country - South America Myomectomy Revenue, (US$, Mn), 2022-2027
Table 28. By Country - Middle East & Africa Myomectomy Revenue, (US$, Mn), 2016-2021
Table 29. By Country - Middle East & Africa Myomectomy Revenue, (US$, Mn), 2022-2027
Table 30. Medtronic Corporate Summary
Table 31. Medtronic Myomectomy Product Offerings
Table 32. Medtronic Myomectomy Revenue (US$, Mn), (2016-2021)
Table 33. Stryker Corporation Corporate Summary
Table 34. Stryker Corporation Myomectomy Product Offerings
Table 35. Stryker Corporation Myomectomy Revenue (US$, Mn), (2016-2021)
Table 36. CONMED Corporation Corporate Summary
Table 37. CONMED Corporation Myomectomy Product Offerings
Table 38. CONMED Corporation Myomectomy Revenue (US$, Mn), (2016-2021)
Table 39. INSIGHTEC Corporate Summary
Table 40. INSIGHTEC Myomectomy Product Offerings
Table 41. INSIGHTEC Myomectomy Revenue (US$, Mn), (2016-2021)
Table 42. CooperSurgical Inc. Corporate Summary
Table 43. CooperSurgical Inc. Myomectomy Product Offerings
Table 44. CooperSurgical Inc. Myomectomy Revenue (US$, Mn), (2016-2021)
Table 45. Hologic, Inc. Corporate Summary
Table 46. Hologic, Inc. Myomectomy Product Offerings
Table 47. Hologic, Inc. Myomectomy Revenue (US$, Mn), (2016-2021)
Table 48. Intuitive Surgical Corporate Summary
Table 49. Intuitive Surgical Myomectomy Product Offerings
Table 50. Intuitive Surgical Myomectomy Revenue (US$, Mn), (2016-2021)
Table 51. Karl Storz Corporate Summary
Table 52. Karl Storz Myomectomy Product Offerings
Table 53. Karl Storz Myomectomy Revenue (US$, Mn), (2016-2021)
Table 54. B. Braun Melsungen AG Corporate Summary
Table 55. B. Braun Melsungen AG Myomectomy Product Offerings
Table 56. B. Braun Melsungen AG Myomectomy Revenue (US$, Mn), (2016-2021)

List Of Figures

LIST OF FIGURES

Figure 1. Myomectomy Segment by Type
Figure 2. Myomectomy Segment by Application
Figure 3. Global Myomectomy Market Overview: 2020
Figure 4. Key Caveats
Figure 5. Global Myomectomy Market Size: 2021 VS 2027 (US$, Mn)
Figure 6. Global Myomectomy Revenue, 2016-2027 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Myomectomy Revenue in 2020
Figure 8. By Type - Global Myomectomy Revenue Market Share, 2016-2027
Figure 9. By Application - Global Myomectomy Revenue Market Share, 2016-2027
Figure 10. By Region - Global Myomectomy Revenue Market Share, 2016-2027
Figure 11. By Country - North America Myomectomy Revenue Market Share, 2016-2027
Figure 12. US Myomectomy Revenue, (US$, Mn), 2016-2027
Figure 13. Canada Myomectomy Revenue, (US$, Mn), 2016-2027
Figure 14. Mexico Myomectomy Revenue, (US$, Mn), 2016-2027
Figure 15. By Country - Europe Myomectomy Revenue Market Share, 2016-2027
Figure 16. Germany Myomectomy Revenue, (US$, Mn), 2016-2027
Figure 17. France Myomectomy Revenue, (US$, Mn), 2016-2027
Figure 18. U.K. Myomectomy Revenue, (US$, Mn), 2016-2027
Figure 19. Italy Myomectomy Revenue, (US$, Mn), 2016-2027
Figure 20. Russia Myomectomy Revenue, (US$, Mn), 2016-2027
Figure 21. Nordic Countries Myomectomy Revenue, (US$, Mn), 2016-2027
Figure 22. Benelux Myomectomy Revenue, (US$, Mn), 2016-2027
Figure 23. By Region - Asia Myomectomy Revenue Market Share, 2016-2027
Figure 24. China Myomectomy Revenue, (US$, Mn), 2016-2027
Figure 25. Japan Myomectomy Revenue, (US$, Mn), 2016-2027
Figure 26. South Korea Myomectomy Revenue, (US$, Mn), 2016-2027
Figure 27. Southeast Asia Myomectomy Revenue, (US$, Mn), 2016-2027
Figure 28. India Myomectomy Revenue, (US$, Mn), 2016-2027
Figure 29. By Country - South America Myomectomy Revenue Market Share, 2016-2027
Figure 30. Brazil Myomectomy Revenue, (US$, Mn), 2016-2027
Figure 31. Argentina Myomectomy Revenue, (US$, Mn), 2016-2027
Figure 32. By Country - Middle East & Africa Myomectomy Revenue Market Share, 2016-2027
Figure 33. Turkey Myomectomy Revenue, (US$, Mn), 2016-2027
Figure 34. Israel Myomectomy Revenue, (US$, Mn), 2016-2027
Figure 35. Saudi Arabia Myomectomy Revenue, (US$, Mn), 2016-2027
Figure 36. UAE Myomectomy Revenue, (US$, Mn), 2016-2027
Figure 37. Medtronic Myomectomy Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 38. Stryker Corporation Myomectomy Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 39. CONMED Corporation Myomectomy Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 40. INSIGHTEC Myomectomy Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 41. CooperSurgical Inc. Myomectomy Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 42. Hologic, Inc. Myomectomy Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 43. Intuitive Surgical Myomectomy Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 44. Karl Storz Myomectomy Revenue Year Over Year Growth (US$, Mn) & (2016-2021)